Accueil

PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Study Description: 
The purpose of this study is to test the safety and effectiveness of infliximab in patients with plaque psoriasis who have been receiving the drug etanercept for treatment of their plaque psoriasis for at least four months, without enough improvement in their psoriasis symptoms.
Maladies et affections de la peau: 
Psoriasis
Study Start Date: 
juillet 2007
Estimated completion date: 
février 2009
Study Location(s): 
Vancouver, Moncton, Hamilton
Province: 
British Columbia
New Brunswick
Ontario
Agegroup: 
18-75
Gender: 
Both
Healthy Volunteers: 
No
Study Director/Investigator: 
Centocor, Inc. Clinical Trial Centocor, Inc.
Pour nous joindre: 
info1@veritasmedicine.com
Additional Information: 
To learn whether you qualify for this trial click cut and paste this URL into your Internet browser and answer the questions found there: http://host.veritasmedicine.com/index.cfm?vip=2811-872-252200

Contact Information:

Canadian Skin Patient Alliance
2446 Bank Street, Suite 383
Ottawa, Ontario
K1V 1A8
 

Christine Jackson, Executive Director
phone: 613-422-4265
fax: 613-422- 4267
 

pageTracker._trackPageview();